Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/1997

01-06-1997

Increased hematopoietic progenitor cell maintenance in long-term bone marrow cultures containing minimal numbers of contaminating breast cancer cells

Authors: S.L. Mann, S.S. Joshi, D.A. Crouse, J.O. Armitage, A. Kessinger, D.D. Weisenburger, W.P. Vaughan, J.G. Sharp

Published in: Breast Cancer Research and Treatment | Issue 2/1997

Login to get access
Metadata
Title
Increased hematopoietic progenitor cell maintenance in long-term bone marrow cultures containing minimal numbers of contaminating breast cancer cells
Authors
S.L. Mann
S.S. Joshi
D.A. Crouse
J.O. Armitage
A. Kessinger
D.D. Weisenburger
W.P. Vaughan
J.G. Sharp
Publication date
01-06-1997
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 2/1997
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1005732531318

Other articles of this Issue 2/1997

Breast Cancer Research and Treatment 2/1997 Go to the issue

OriginalPaper

Prognostic factors for metachronous contralateral breast cancer: A comparison of the linear Cox regression model and its artificial neural network extension

OriginalPaper

Gene therapy strategies for carcinoma of the breast

OriginalPaper

MRI in patients with axillary metastases of occult breast carcinoma

OriginalPaper

Isolation and analysis of different subpopulations of normal human breast epithelial cells early after their infection with a retroviral vector encoding a cell surface marker

OriginalPaper

Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact?

OriginalPaper

The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits